Comparative Efficacy And Side Effects Of Alemtuzumab Versus Basiliximab As Induction Agent In Lung Transplantation

被引：0
|
作者：
Kolman, D. [1 ]
Shapiro, W. [1 ]
Zhao, H. [1 ]
Butler-LeBair, M. [1 ]
Patel, N. [1 ]
Shiose, A. [1 ]
Toyoda, Y. [1 ]
Criner, G. J. [1 ]
Cordova, F. C. [1 ]
机构：
[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5168
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience
    Yakubu, Idris
    Ravichandran, Bharath
    Sparkes, Tracy
    Barth, Rolf N.
    Haririan, Abdolreza
    Masters, Brian
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (02) : 199 - 206
  • [42] Cladribine versus Alemtuzumab: efficacy and autoimmunity in multiple sclerosis induction treatment
    Schmierer, Klaus
    Herrod, Samuel
    Alvarez-Gonzalez, Cesar
    Baker, David
    NEUROLOGY, 2017, 88
  • [43] Five-year outcomes with alemtuzumab induction after Lung transplantation
    Shyu, Susan
    Dew, Mary Amanda
    Pilewski, Joseph M.
    Dabbs, Annette J. DeVito
    Zaldonis, Diana B.
    Studer, Sean M.
    Crespo, Maria M.
    Toyoda, Yoshiya
    Bermudez, Christian A.
    McCurry, Kenneth R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (07): : 743 - 754
  • [44] Long-Term Outcomes following Alemtuzumab Induction in Lung Transplantation
    Wehman, Brody
    Griffith, Bartley P.
    Balwan, Akshu
    Kon, Zachary N.
    Suffredini, Dante A.
    Evans, Charles
    Garcia, Jose P.
    Iacono, Aldo
    HEART SURGERY FORUM, 2013, 16 (05): : E252 - E256
  • [45] Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis
    Sun, Z. -J.
    Du, X.
    Su, L. -L.
    Zhang, X. -D.
    Wang, W.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (08) : 2439 - 2445
  • [46] Our unique experience with low dose Alemtuzumab as induction agent in renal transplantation
    Champannoor, Cherin
    Sundar, Divya
    Matthew, Milly
    Kumar, Prem
    Vaidya, Anil
    Abraham, Georgi
    TRANSPLANTATION, 2024, 108 (09) : 340 - 340
  • [47] Efficacy and safety of basiliximab induction therapy in adult living donor liver transplantation.
    Furukawa, H
    Shimamura, T
    Suzuki, T
    Taniguchi, M
    Kamiyama, T
    Matsushita, M
    Todo, S
    LIVER TRANSPLANTATION, 2005, 11 (07) : C45 - C45
  • [48] Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation
    Clark, G
    Walsh, G
    Deshpande, P
    Koffman, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (07) : 1304 - 1309
  • [49] Basiliximab induction in lung transplantation: A single center description of survival, acute rejection and infection
    Stuckey, L. J.
    Han, M. K.
    Florn, R.
    Walls, C.
    Flaherty, K. R.
    Lama, V. N.
    Gay, S.
    Ojo, T.
    Martinez, F. J.
    Pickens, A.
    Chang, A. C.
    Chan, K. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S83 - S84
  • [50] A comparison of basiliximab and anti-thymocyte globluin as induction agents after lung transplantation
    Hachem, RR
    Chakinala, MM
    Yusen, RD
    Lynch, JP
    Aloush, AA
    Patterson, GA
    Trulock, EP
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (09): : 1320 - 1326
12345